We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.49B
AUM Growth
+$308M
Cap. Flow
-$9.33M
Cap. Flow %
-0.27%
Top 10 Hldgs %
56.89%
Holding
645
New
145
Increased
110
Reduced
156
Closed
135

Top Buys

Rank Stock Value
1
JNPR
Juniper Networks
JNPR
+$162M
2
AXNX
Axonics, Inc. Common Stock
AXNX
+$128M
3
ANSS
Ansys
ANSS
+$119M
4
X
US Steel
X
+$104M
5
CTLT
CATALENT, INC.
CTLT
+$93.3M

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$561M
2
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$120M
3
IMGN
Immunogen Inc
IMGN
+$56.8M
4
CPRI icon
Capri Holdings
CPRI
+$44.2M
5
PXD
Pioneer Natural Resource Co.
PXD
+$34M

Sector Composition

Rank Sector Weight
1 Energy 34.28%
2 Technology 15.43%
3 Healthcare 14.7%
4 Industrials 8%
5 Materials 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BGS icon
401
PUT
B&G Foods
BGS
$278M
$132K ﹤0.01%
117,500
-107,500
-48% -$1.13M
BCYC
402
CALL
Bicycle Therapeutics
BCYC
$278M
$130K ﹤0.01%
70,000
-55,000
-44% -$1.17M
NVCR icon
403
CALL
NovoCure
NVCR
$1.83B
$120K ﹤0.01%
+100,000
New +$1.47M
MGM icon
404
PUT
MGM Resorts International
MGM
$11.2B
$118K ﹤0.01%
75,000
+40,000
+114% +$1.75M
GAQ.WS
405
DELISTED
Generation Asia I Acquisition Limited Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GAQ.WS
$117K ﹤0.01%
938,800
– –
UBX
406
DELISTED
Unity Biotechnology
UBX
$115K ﹤0.01%
70,397
-22,303
-24% -$38.7K
AEON.WS
407
DELISTED
AEON Biopharma Inc
AEON.WS
$114K ﹤0.01%
74,997
– –
BHVN icon
408
CALL
Biohaven
BHVN
$2.17B
$110K ﹤0.01%
+23,000
New +$1.14M
STWD icon
409
PUT
Starwood Property Trust
STWD
$5.9B
$104K ﹤0.01%
65,600
-35,600
-35% -$721K
M icon
410
CALL
Macy's
M
$6.61B
$103K ﹤0.01%
+150,000
New +$2.9M
AFMD
411
DELISTED
Affimed
AFMD
$101K ﹤0.01%
19,071
-6,423
-25% -$36.6K
VERA icon
412
CALL
Vera Therapeutics
VERA
$2.3B
$97K ﹤0.01%
+20,000
New +$713K
PMVP icon
413
PMV Pharmaceuticals
PMVP
$62.9M
$96.6K ﹤0.01%
56,852
-69,148
-55% -$129K
CHGG icon
414
Chegg
CHGG
$98.4M
$94.6K ﹤0.01%
12,500
-12,500
-50% -$115K
LVS icon
415
PUT
Las Vegas Sands
LVS
$29.9B
$93.2K ﹤0.01%
+21,800
New +$1.12M
VERA icon
416
PUT
Vera Therapeutics
VERA
$2.3B
$83K ﹤0.01%
+20,000
New +$713K
EXPE icon
417
PUT
Expedia Group
EXPE
$36.8B
$82.2K ﹤0.01%
13,000
+2,000
+18% +$284K
MRNA icon
418
CALL
Moderna
MRNA
$21.5B
$68.5K ﹤0.01%
20,000
+8,000
+67% +$806K
CLBR.WS
419
DELISTED
Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
CLBR.WS
$63.3K ﹤0.01%
+133,333
New +$58K
MAR icon
420
PUT
Marriott International
MAR
$93.8B
$63.2K ﹤0.01%
+16,000
New +$3.87M
RAPT
421
CALL
DELISTED
RAPT Therapeutics
RAPT
$63.1K ﹤0.01%
+3,125
New +$434K
MAT icon
422
CALL
Mattel
MAT
$4.21B
$62.3K ﹤0.01%
172,500
– –
RARE icon
423
CALL
Ultragenyx Pharmaceutical
RARE
$2.55B
$61K ﹤0.01%
10,700
+700
+7% +$33K
M icon
424
PUT
Macy's
M
$6.61B
$60K ﹤0.01%
60,000
-71,000
-54% -$1.37M
XAGEW
425
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$56.5K ﹤0.01%
371,250
– –
15 16
17
18 19

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2024 Portfolio in Review

As of Q1 2024, UBS O'Connor held 645 positions worth $3.49B, up 9.7% from $3.18B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor's Q1 2024 filing shows 145 new, 110 increased, 156 reduced and 135 closed positions. Its largest new stake was Juniper Networks: 4,428,704 shares worth $164M. The largest sale was Splunk Inc, an estimated $561M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q1 2024 buy was Juniper Networks: 4,428,704 shares worth $164M.
  • UBS O'Connor added most to Axonics, Inc. Common Stock in Q1 2024, an estimated $128M increase.
  • UBS O'Connor's biggest Q1 2024 reduction was Pioneer Natural Resource Co., cutting an estimated $34M.
  • UBS O'Connor fully exited Splunk Inc in Q1 2024, selling an estimated $561M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.49B portfolio in Q1 2024.
  • UBS O'Connor opened 145 new positions and closed 135 in Q1 2024.
  • UBS O'Connor's portfolio value rose 9.7% quarter-over-quarter to $3.49B.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.